Among patients diagnosed with adenocarcinoma, mutational analysis was performed in 13 cases, one patient showed EGFR mutation, four patients KRAS mutation, while PD‐L1 expression was confirmed in three samples. Here, EGFR is linked to adenocarcinoma.